Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183198

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
123,769,000 EUR
110,922,000 EUR
Revenue
22,668,000 EUR
9,030,000 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
74,387,000 EUR
80,025,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
54,682,000 EUR
16,207,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
23,245,000 EUR
185,187,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.